Gaush Meditech Ltd (HKG:2407)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.500
-0.060 (-1.32%)
Oct 2, 2026, 3:55 PM HKT

Gaush Meditech Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,3221,3801,4281,4061,2541,298
Revenue Growth
-4.20%-3.36%1.58%12.16%-3.42%34.94%
Gross Profit
597.57624.87653.96684.6621.25601.61
Operating Income
86.58112.61194.55253.3227.03243.32
Net Income
75.4996.1992.39173.52-349.62-190.45
Earnings Per Share
0.530.660.631.17-3.61-1.99
EPS Growth
-20.69%6.05%-46.68%---

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Intersegment Sales
-131.03-131.81-149.34-154.54-81.25-84.45
Technical Services
235.96238.47226.46209.23190.08161.61
Distribution Products
634697.6819.32808.91744.81810.99
Others
13.8214.926.810.4311.0918.41
Proprietary Products
569.67561.17525.15532.21389.05391.67
Total
1,3221,3801,4281,4061,2541,298

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
353.32437.66518.99832.97814.16609
Total Debt
402.57507.15552.24664.367562,622
Net Cash (Debt)
-49.25-69.49-33.24168.6158.16-2,013
Net Cash Growth
---189.92%--
Net Cash Per Share
-0.34-0.48-0.221.140.60-21.00

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
163.99144.23107.78249.04234.42164.49
Capital Expenditures
-23.96-22.77-14.67-34.92-45.4-26.55
Free Cash Flow
140.03121.4693.12214.11189.03137.94
Free Cash Flow Growth
15.29%30.44%-56.51%13.27%37.04%7.57%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
45.19%45.27%45.78%48.68%49.55%46.34%
Operating Margin
6.55%8.16%13.62%18.01%18.11%18.74%
Pretax Margin
6.40%8.31%10.87%17.62%-21.94%-10.63%
Profit Margin
5.71%6.97%6.47%12.34%-27.88%-14.67%
FCF Margin
10.59%8.80%6.52%15.23%15.08%10.63%

Dividends

Fiscal YearFY 2024FY 2023
Period EndingDec '24 Dec '23
Dividend Per Share
0.2820.998
Dividend Per Share Growth
-71.77%-
Dividend Yield
3.19%3.31%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
7.4111.1914.7929.26--
Forward PE
-15.0915.0920.04--
P/FCF Ratio
3.948.8614.6723.7135.69-
PS Ratio
0.420.780.963.615.38-